Director Yeshwant Reports an $18 Million VERV Purchase

JC Parets
December 6, 2023

From the Desk of Steve Strazza and Alfonso Depablos

The largest insider buy on today’s list comes in a Form 4 filing by Verve Therapeutics Inc $VERV director Krishna Yeshwant.

Yeshwant reported an $18 million purchase of VERV shares.

Graham Walmsley, director of Akero Therapeutics $AKRO, revealed the acquisition of 100,000 shares.

Here’s The Hot Corner, with data through December 5, 2023:

Over in Washington, Rep. Jonathan Jackson of Illinois reported a purchase worth between $15,000 and $50,000 in NVIDIA Corporation $NVDA.

In the options market, there was bullish flow in Darling Ingredients Inc $DAR, PagerDuty Inc $PD, Torrid Holdings Inc $CURV, and Samsara Inc $IOT.

Stay tuned. We'll be back on Thursday with more insider activity.

If you want these insider transactions e-mailed to you every morning, click here to sign up for The Hot Corner.

And please reach out with any questions. We love hearing from you!

All Star Charts Team

Filed Under